King BM - Search Results

1

Treatment of canine fucosidosis by intracisternal enzyme infusion.

Kondagari GS, King BM, Thomson PC, Williamson P, Clements PR, Fuller M, Hemsley KM, Hopwood JJ, Taylor RM. Kondagari GS, et al. Among authors: king bm. Exp Neurol. 2011 Aug;230(2):218-26. doi: 10.1016/j.expneurol.2011.04.019. Epub 2011 May 6. Exp Neurol. 2011. PMID: 21575633

2

Sulfate transport in normal and cystic fibrosis fibroblasts.

King BM, Rozaklis T, Hopwood JJ, Harper GS. King BM, et al. Biochem Med Metab Biol. 1992 Jun;47(3):260-4. doi: 10.1016/0885-4505(92)90034-v. Biochem Med Metab Biol. 1992. PMID: 1627357

3

Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.

Crawley AC, Brooks DA, Muller VJ, Petersen BA, Isaac EL, Bielicki J, King BM, Boulter CD, Moore AJ, Fazzalari NL, Anson DS, Byers S, Hopwood JJ. Crawley AC, et al. Among authors: king bm. J Clin Invest. 1996 Apr 15;97(8):1864-73. doi: 10.1172/JCI118617. J Clin Invest. 1996. PMID: 8621770 Free PMC article.

4

Enzyme replacement therapy in Mucopolysaccharidosis VI: evidence for immune responses and altered efficacy of treatment in animal models.

Brooks DA, King BM, Crawley AC, Byers S, Hopwood JJ. Brooks DA, et al. Among authors: king bm. Biochim Biophys Acta. 1997 Aug 22;1361(2):203-16. doi: 10.1016/s0925-4439(97)00036-7. Biochim Biophys Acta. 1997. PMID: 9300802 Free article.

5

Immune response to enzyme replacement therapy: clinical signs of hypersensitivity reactions and altered enzyme distribution in a high titre rat model.

Brooks DA, Hopwood JJ, King BM. Brooks DA, et al. Among authors: king bm. Biochim Biophys Acta. 1998 Aug 14;1407(2):163-72. doi: 10.1016/s0925-4439(98)00034-9. Biochim Biophys Acta. 1998. PMID: 9685627 Free article.

6

Recombinant caprine 3H-[N-acetylglucosamine-6-sulfatase] and human 3H-[N-acetylgalactosamine-4-sulfatase]: plasma clearance, tissue distribution, and cellular uptake in the rat.

Jones MZ, Brumfield LK, King BM, Hopwood JJ, Byers S. Jones MZ, et al. Among authors: king bm. J Mol Neurosci. 1998 Dec;11(3):223-32. doi: 10.1385/JMN:11:3:223. J Mol Neurosci. 1998. PMID: 10344792

7

Caprine mucopolysaccharidosis IIID: a preliminary trial of enzyme replacement therapy.

Downs-Kelly E, Jones MZ, Alroy J, Cavanagh KT, King B, Lucas RE, Baker JC, Kraemer SA, Hopwood JJ. Downs-Kelly E, et al. J Mol Neurosci. 2000 Dec;15(3):251-62. doi: 10.1385/JMN:15:3:251. J Mol Neurosci. 2000. PMID: 11303788

8

Caprine mucopolysaccharidosis IIID: fetal and neonatal brain and liver glycosaminoglycan and morphological perturbations.

Jones MZ, Alroy J, Downs-Kelly E, Lucas RE, Kraemer SA, Cavanagh KT, King B, Hopwood JJ. Jones MZ, et al. J Mol Neurosci. 2004;24(2):277-91. doi: 10.1385/JMN:24:2:277. J Mol Neurosci. 2004. PMID: 15456941

9

Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA.

King B, Savas P, Fuller M, Hopwood J, Hemsley K. King B, et al. Mol Genet Metab. 2006 Feb;87(2):107-12. doi: 10.1016/j.ymgme.2005.09.026. Epub 2005 Dec 13. Mol Genet Metab. 2006. PMID: 16352454

10

Enzyme replacement therapy in alpha-mannosidosis guinea-pigs.

Crawley AC, King B, Berg T, Meikle PJ, Hopwood JJ. Crawley AC, et al. Mol Genet Metab. 2006 Sep-Oct;89(1-2):48-57. doi: 10.1016/j.ymgme.2006.05.005. Epub 2006 Jun 27. Mol Genet Metab. 2006. PMID: 16807033

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters